<DOC>
	<DOCNO>NCT02987374</DOCNO>
	<brief_summary>The purpose investigate B-cell response trivalent Influenza Vaccine ( TIV ) healthy young adult vaccinate participant obtain blood sample designate time point vaccination .</brief_summary>
	<brief_title>Pilot Study Young Adults Examine Kinetics Changes B-cell Repertoire Following TIV Immunization</brief_title>
	<detailed_description>This exploratory study use strategy previously employ investigate B-cell response . Investigators collect blood sample volunteer higher frequency two previous flu season well define dynamic response vaccination . The objective compare Ig gene repertoire vaccination deep sequencing PBMC proteomic analysis antibody CDR3 regions 10 different time point immunization . This Phase IV study healthy adult give standard TIV off-season . There exclusion gender , ethnicity race . Following confirmation write informed consent , baseline blood sample draw study participant Day -5 , Day -3 Day 0 prior immunization , Days 1 , 4 , 7 , 9 , 11 , 28 180 post-immunization . Volunteers vaccine-naïve 2010-2011 2011-2012 seasonal influenza vaccine . All participant receive single dose current seasonal influenza vaccine intramuscular ( IM ) injection Day 0 .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Otherwise healthy , 1830 year old young adult . 2 . Availability followup plan duration study least 180 day immunization . 3 . Acceptable medical history medical history vital sign . 1 . Prior vaccination 20102011 seasonal TIV LAIV . 2 . Prior offstudy vaccination current 20112012 seasonal TIV LAIV 3 . Weight le 110 pound . 4 . Allergy egg egg product , vaccine component , include gelatin thimerosal ( thimerosal TIV multidose vial ) . 5 . Lifethreatening reaction previous influenza vaccination 6 . Active systemic serious concurrent illness , include febrile illness day vaccination 7 . History immunodeficiency ( include HIV infection ) 8 . Known suspected impairment immunologic function , include , limited , clinically significant liver disease , diabetes mellitus treat insulin , moderate severe renal disease , chronic disorder , opinion investigator , might jeopardize volunteer safety compliance protocol . 9 . Blood pressure &gt; 150 systolic &gt; 95 diastolic first study visit 10 . Hospitalization past year congestive heart failure emphysema . 11 . Chronic Hepatitis B C. 12 . Recent current use immunosuppressive medication , include systemic glucocorticoid . Corticosteroid nasal spray topical steroid permissible . 13 . Malignancy , squamous cell basal cell skin cancer ( include solid tumor breast cancer prostate cancer recurrence past year , hematologic cancer leukemia ) . 14 . Autoimmune disease ( include rheumatoid arthritis treat immunosuppressive medication Plaquenil , methotrexate , prednisone , Enbrel ) , opinion investigator , might jeopardize volunteer safety compliance protocol . 15 . History blood dyscrasia , renal disease , hemoglobinopathies require regular medical follow hospitalization precede year . 16 . Use anticoagulation medication Coumadin Lovenox , antiplatelet agent aspirin ( except 325 mg. per day ) , Plavix , Aggrenox must review investigator determine would affect volunteer 's safety . 17 . Receipt blood blood product within past 6 month . 18 . Medical psychiatric condition occupational responsibility preclude participant compliance protocol 19 . Receipt inactivate vaccine 14 day prior study enrollment , plan vaccination prior completion Visit 09 ( Day 28 study vaccination ) , plan vaccination 14 day prior Visit 10 ( 6 month study vaccination ) . 20 . Receipt live , attenuated vaccine 60 day prior study enrollment , plan vaccination prior completion Visit 09 ( Day 28 study vaccination ) , plan vaccination 14 day prior Visit 10 ( 6 month study vaccination ) . 21 . History GuillainBarré Syndrome 22 . Pregnant lactate woman 23 . Use investigational agent within 30 day prior study enrollment plan use study period . 24 . Donation equivalent unit blood within 6 week prior study enrollment , first 5 week study participation . 25 . A member study team family member , include investigator , research laboratory staff , clinical research staff . 26 . Any condition , opinion investigator , might interfere volunteer safety , study objective ability participant understand comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Influenza Vaccine</keyword>
</DOC>